Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0476089 (
endometrial cancer
)
11,379
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The identification of target genes at genome-wide association study (GWAS) loci is a major obstacle for GWAS follow-up. To identify candidate target genes at the 16 known
endometrial cancer
GWAS risk loci, we performed HiChIP chromatin looping analysis of endometrial cell lines. To enrich for enhancer-promoter interactions, a mechanism through which GWAS variation may target genes, we captured chromatin loops associated with H3K27Ac histone, characteristic of promoters and enhancers. Analysis of HiChIP loops contacting promoters revealed enrichment for
endometrial cancer
GWAS heritability and intersection with
endometrial cancer
risk variation identified 103 HiChIP target genes at 13 risk loci. Expression of four HiChIP target genes (
SNX11
,
SRP14
,
HOXB2
and
BCL11A
) was associated with risk variation, providing further evidence for their targeting. Network analysis functionally prioritized a set of proteins that interact with those encoded by HiChIP target genes, and this set was enriched for pan-cancer and
endometrial cancer
drivers. Lastly, HiChIP target genes and prioritized interacting proteins were over-represented in pathways related to
endometrial cancer
development. In summary, we have generated the first global chromatin looping data from normal and tumoral endometrial cells, enabling analysis of all known
endometrial cancer
risk loci and identifying biologically relevant candidate target genes.
...
PMID:Analysis of Promoter-Associated Chromatin Interactions Reveals Biologically Relevant Candidate Target Genes at Endometrial Cancer Risk Loci. 3156 79